Drug addiction: Bad habits add up

Nature

Volumn 398, Issue 6728, 1999, Pages 567-570

  Robbins, Trevor W ^a   Everitt, Barry J ^a  

^a UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABIS; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; LYSERGIDE; METHYLPHENIDATE; NICOTINE; OPIATE; PHENCYCLIDINE; SEROTONIN;

ADDICTION; AMYGDALOID NUCLEUS; CAUDATE NUCLEUS; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DEPENDENCE; GENE EXPRESSION; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROTRANSMISSION; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; VENTRAL TEGMENTUM;

BRAIN; CAUSALITY; DOPAMINE; HUMANS; LEARNING; RECURRENCE; SEROTONIN; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

CANNABIS;

EID: 0033561459     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/19208     Document Type: Review

References (32)

1. Wise, R. A. & Bozarth, M. Psychol. Rev. 94, 469-492 (1987).
2. Hoebel, B. G. et al. Psychopharmacology 81, 158-165 (1983).
3. Bozarth, M. A. & Wise, R. A. Life Sci. 28, 551-555 (1981).
4. Rossetti, Z. L. et al. Eur. J. Pharmacol. 211, 227-234 (1992).
5. Koob, G. F. & Le Moal, M. Science 278, 52-58 (1997).
6. Volkow, N. et al. Nature 384, 830-833 (1997).
7. Uhl, G. Neuropsychopharmaology 20, 3-9 (1999).
8. Phillips,T. J. et al. Nature Neurosci. 1, 610-615 (1998).
9. Maldonado, R. et al. Nature 388, 586-589 (1997).
10. Harris, G. C. & Aston-Jones, G. Nature 371, 155-157 (1994).
11. Rocha, B. A. et al. Nature 393, 175-178 (1998).
12. Volkow, N. D. et al. Nature 386, 827-830 (1997).
13. Markou, A. et al. Neuropsychopharmacology 18, 135-174 (1998).
14. Rocha, B. et al. Nature Neurosci. 1, 132-137 (1998).
15. Parsons, L. et al. J. Neurosci. 18, 10078-10089 (1998).
16. Self, D. W. & Nestler, E. J. Drug Alcohol Depend. 51, 49-60 (1998).
17. Mendelson, J. H. et al. Neuropsychopharmacology 8, 263-271 (1998).
18. Robinson, T. E. & Berridge, K. C. Brain Res. Rev. 18, 247-291 (1993).
19. O'Brien, C. P. & McLennan, A. T. Lancet 347, 237-240 (1996).
20. Whitelaw, R. et al. Psychopharmacology 127, 213-224 (1996).
21. Grant, S. et al. Proc. Natl Acad. Sci. USA 93, 12040-12045 (1996).
22. Breiter, H. C. et al. Neuron 19, 591-611 (1997).
23. Tiffany, S. T. Psychol. Rev. 97, 147-168 (1990).
24. White, N. M. Addiction 91, 921-949 (1996).
25. Schultz, W. et al. Science 275, 1593-1599 (1997).
26. Herman, B. H. et al. Neuropsychopharmacology 13, 269-293 (1995).
27. Shaham, Y. et al. J. Neurosci. 16, 1957-1963 (1996).
28. Pilla, M. et al. J. Pychopharm. 11S, A5 (1997).
29. Meil, W. M. & See, R. E. Behav. Brain Res. 87, 139-148 (1997).
30. Rogers, R. D. et al. Neuropsychopharmacology 20, 322-339 (1999).
31. Wilson, J. M. et al. Nature Med. 2, 699-703 (1996).
32. McCann, U. D. et al. Lancet 352, 1433-1437 (1998).